Findings of reduced risks for mortality and major CVD suggest consideration of statins in all adults with type 2 diabetes, even in those with low short-term predicted CVD risk.
The target trial emulation study suggests rigid risk thresholds aren’t needed to steer statin use in this group.
In February 2024, the U.S. Department of Health and Human Services Panel for the Use of Antiretroviral Agents in Adults and Adolescents with HIV (ARV Guidelines Panel), in collaboration with the ...
HDL, the so-called good cholesterol, appears to influence treatment decisions around statin therapy, according to an analysis in JACC: Advances. Compared with people who have normal HDL-cholesterol ...
Elizabeth Cooney is a cardiovascular disease reporter at STAT, covering heart, stroke, and metabolic conditions. You can reach Liz on Signal at LizC.22. It’s a math problem with life-and-death ...
Patients who received high-intensity statin therapy had a 23% elevated risk for developing type 2 diabetes (T2D) compared to those on low-intensity statins, the results of a large study showed. In ...
Please provide your email address to receive an email when new articles are posted on . Using visualized coronary calcium scoring independently reduced plaque progression among patients at ...
NEW ORLEANS, LOUISIANA / ACCESS Newswire / November 12, 2025 / American Heart Association (“AHA”) Conference 2025, GENinCode the predictive genetics company focused on the prevention of cardiovascular ...
The analysis included 16,501 participants: 3610 statin users and 12,891 nonusers. HealthDay News — For patients with chronic liver disease, statin use is associated with a reduced risk for ...
Harvard Medical School researchers have found that statin use significantly reduces the risk of hepatocellular carcinoma (HCC ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback